Vivet Therapeutics Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Vivet Therapeutics's estimated annual revenue is currently $5.7M per year.(i)
  • Vivet Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Vivet Therapeutics has 37 Employees.(i)
  • Vivet Therapeutics grew their employee count by -7% last year.

Vivet Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$12.6M81-5%N/AN/A
#2
$19.5M126-2%N/AN/A
#3
$36.3M23422%N/AN/A
#4
$19.7M127-17%N/AN/A
#5
$14.3M920%$179.5MN/A
#6
$49.4M208-8%€201.1MN/A
#7
$44.5M287-3%N/AN/A
#8
$7.6M49N/AN/AN/A
#9
$6.4M41N/AN/AN/A
#10
$17.2M111-15%N/AN/A
Add Company

What Is Vivet Therapeutics?

Vivet Therapeutics is dedicated to developing innovative gene therapy treatments for orphan diseases. Vivet Therapeutics is focused on optimizing gene therapy through collaborating with the Fundacion para la Investigacion Medica Aplicada (CIMA, Universidad de Navarra) to develop new AAV vectors specifically targeting the liver and generating new technologies to optimize gene delivery and long term expression.

keywords:N/A

N/A

Total Funding

37

Number of Employees

$5.7M

Revenue (est)

-7%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Vivet Therapeutics News

2022-04-19 - Noxxon Reports 2021 Financial Results

... including immune checkpoint inhibitors and cell therapies as well as ... General Counsel and Head of Finance at Vivet Therapeutics,...

2022-04-06 - Intrahepatic Cholangiocarcinoma Clinical Trial Pipeline ...

Key Intrahepatic Cholangiocarcinoma pipeline therapies in various ... such as Mirum Pharmaceuticals, Vivet Therapeutics, among others.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.5M37-20%N/A
#2
$4.3M37N/AN/A
#3
$9M3712%N/A
#4
$6.9M3712%N/A
#5
$4.3M376%N/A